BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 14970278)

  • 1. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
    Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
    J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of TSLC1 gene methylation and TSLC1 protein expression in the progression of cervical lesions].
    Zhao X; Cui Y; Li Y; Liang S; Zhang Y; Xie L; Xia Z; Du J; Wei L; Li Y
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):356-60. PubMed ID: 26463026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.
    Overmeer RM; Henken FE; Snijders PJ; Claassen-Kramer D; Berkhof J; Helmerhorst TJ; Heideman DA; Wilting SM; Murakami Y; Ito A; Meijer CJ; Steenbergen RD
    J Pathol; 2008 Aug; 215(4):388-97. PubMed ID: 18498117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of tumor suppressor in lung cancer 1 gene expression in cervical carcinogenesis.
    Yang YX; Yang AH; Yang ZJ; Wang ZR; Xia XH
    Int J Gynecol Cancer; 2006; 16(5):1868-72. PubMed ID: 17009984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
    Overmeer RM; Henken FE; Bierkens M; Wilting SM; Timmerman I; Meijer CJ; Snijders PJ; Steenbergen RD
    J Pathol; 2009 Nov; 219(3):327-36. PubMed ID: 19662663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
    Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
    Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.
    Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B
    Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines.
    Honda T; Tamura G; Waki T; Jin Z; Sato K; Motoyama T; Kawata S; Kimura W; Nishizuka S; Murakami Y
    Jpn J Cancer Res; 2002 Aug; 93(8):857-60. PubMed ID: 12716461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
    Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study.
    McCormick TM; Canedo NH; Furtado YL; Silveira FA; de Lima RJ; Rosman AD; Almeida Filho GL; Carvalho Mda G
    Diagn Pathol; 2015 Jun; 10():59. PubMed ID: 26032781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
    Fukami T; Fukuhara H; Kuramochi M; Maruyama T; Isogai K; Sakamoto M; Takamoto S; Murakami Y
    Int J Cancer; 2003 Oct; 107(1):53-9. PubMed ID: 12925956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesis.
    Steenbergen RD; OudeEngberink VE; Kramer D; Schrijnemakers HF; Verheijen RH; Meijer CJ; Snijders PJ
    Am J Pathol; 2002 Jun; 160(6):1945-51. PubMed ID: 12057898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.
    Wei X; Zhang S; Cao D; Zhao M; Zhang Q; Zhao J; Yang T; Pei M; Wang L; Li Y; Yang X
    PLoS One; 2015; 10(12):e0145700. PubMed ID: 26697877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
    Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
    Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.
    Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M
    Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
    Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
    J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities.
    Hopman AH; Smedts F; Dignef W; Ummelen M; Sonke G; Mravunac M; Vooijs GP; Speel EJ; Ramaekers FC
    J Pathol; 2004 Jan; 202(1):23-33. PubMed ID: 14694518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.